Inogen PE ratio INGN

Share price divided by earnings per share over the last twelve months, since 2015.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 59.4×; Feb 2022
10-year median: 79.2×
10-year range: 22.7× to 198×
Peer median: 19.7×

Inogen has no meaningful PE ratio today: it lost $0.90 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2022, at 59.4×.

On the days it had one over the last ten years, its median was 79.2×, from 22.7× in Aug 2019 to 198× in Sep 2018.

PE ratio over time

median 79.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	59.4×	59.4×	66.3×
2021	69.4×	62.9×	75.3×
2020	97.4×	30.6×	116×
2019	47.6×	22.7×	83.2×
2018	66.9×	63.0×	198×
2017	96.8×	72.6×	101×
2016	94.6×	66.9×	95.6×
2015	89.1×	81.3×	129×

Against its peers

Companies in Medical - Instruments & Supplies nearest Inogen's size, closest first, today.

Company	PE ratio
INGNInogen	n/m
PDEXPro DEX	15.1×
UTMDUtah Medical Products	22.6×
INFUInfuSystem	34.0×
KEQUKewaunee Scientific	11.9×
EMBCEmbecta	4.6×
TCMDTactile Systems Technology	21.9×
MDXGMimedx	97.8×
APTAlpha Pro Tech	13.6×
MOVMovado	17.5×
NEPHNephros	22.1×
Peer median	19.7×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Inogen

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.